Related Experiment Video

Updated: Jun 24, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer

Hee Jun Cho1, Kyoung Eun Baek, Sun-Mi Park

  • 1Department of Microbiology/Research Institute of Life Science, College of Natural Sciences, Physiology, Anatomy and Neurobiology, Institute of Health Science, Gyeongsang National University, Jinju, Korea.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|April 9, 2009
PubMed
Abstract

Insights

Rho GDP dissociation inhibitor 2 (RhoGDI2) promotes gastric tumor growth and metastasis. This suggests RhoGDI2 could be a valuable biomarker for tracking cancer progression in patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Rho GDP dissociation inhibitor 2 (RhoGDI2) regulates Rho family GTPase, but its role in cancer is debated.
  • Previous studies lacked in vivo evidence on RhoGDI2's specific function and impact on tumor development.

Purpose of the Study:

  • To investigate the role of RhoGDI2 in gastric tumor growth and metastasis.
  • To determine if RhoGDI2 acts as an activator or inhibitor of Rho GTPases in vivo.
  • To assess RhoGDI2 as a potential biomarker for gastric cancer progression.

Main Methods:

  • Proteomic analysis identified RhoGDI2 in gastric cancer.
  • Immunohistochemistry assessed RhoGDI2 expression in clinical gastric tumor samples.
  • Gain-of-function and loss-of-function studies evaluated RhoGDI2's effect on cancer cell phenotypes.

Main Results:

  • RhoGDI2 expression positively correlated with tumor progression and metastasis in human gastric tissues and cell lines.
  • Increased RhoGDI2 expression enhanced gastric cancer cell invasion, tumor growth, angiogenesis, and metastasis.
  • Decreased RhoGDI2 expression showed opposite effects, inhibiting these malignant phenotypes.

Conclusions:

  • RhoGDI2 significantly contributes to gastric tumor growth and metastasis.
  • RhoGDI2 may serve as a predictive biomarker for tumor progression in human gastric cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...